Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO): Therapeutic Option for Patients with COVID-19 EssayVenous-venous extracorporeal membrane oxygenation (VV ECMO) is one of the therapeutic options for patients with respiratory insufficiency secondary to coronavirus disease 2019 (COVID-19). VV ECMO provides extracorporeal respiratory support; thus, the lungs are allowed to rest and heal. VV ECMO was indicated for patients with acute respiratory distress syndrome (ARDS) caused by hypoxemia due to COVID-19.Why VV ECMO For COVID-19?Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to COVID-19, which can present with severe SARS-CoV-2-associated acute respiratory distress syndrome (ARDS). Older people with comorbidity and severe pneumonia